Genya V. Dana

Head of Precision Medicine at the World Economic Forum.

She leads the co-design, testing and scaling of pilot projects with governments, industry, civil society, and academia to tackle policy and governance challenges around moving toward a tailored and personalized approach to health and healthcare.

• An internationally recognized expert on the policy and science of synthetic biology and gene editing, and has advised foreign policy makers on the implications of emerging technologies.
• She served as a U.S. negotiator on science, technology and innovation in multi-lateral organizations like the United Nations, worked to advance science, technology and innovation for sustainable development with a focus on Africa, and developed international partnerships to support scientific research on brain science and biological engineering.
• Degrees in biology, public policy, and risk assessment
• PhD research in South Africa.